Controlled Release of Haloperidol from a novel SWCNT Nano composite coated with ZnO nanocrystals.
Date
2023
Journal Title
Journal ISSN
Volume Title
Publisher
Univesidsad Tecnológica Nacional
Abstract
Starting from the physicochemical knowledge of the host properties of the na noscale
systems would be applied to drug dosage [1,2]. We propose NM synthesis strategies
that offer the necessary characteristics for these processes. First, we study the
physicochemistry of the anchoring sites of the respective hosts (chemical bonds with
reversible or irreversible adsorption) or physisorption (straightforward interactions).
Then, whether to design carbon based nanomaterials (CNM), or nano engineered
materials, containing the respective active sites (deposited or generated nanospecies),
capable of interacting with the aforementioned hosts such as: redox sites, proton
acceptor sites, electron donor-acceptor sites, to allow HOMO-LUMO chemical
interactions that satisfy the needs of the process to be studied.
The nanostructures that allow free diffusions and reversible adsorptions, dosage of
molecules with applications in nanokinetics, etc., and determination of critical molecular
sizes, calculated using experimental methods, and methods such as density functional
theory and semiempirical methods, to avoid steric hindrances between molecules and
100
80
40
60
8 12 16 20
Experimental data
Weibull Ritger-Peppas
Higuchi Drug Released , % mol/w
Time (h) 4
20
nanomaterials whether 2D or 3D, designing NMs with large surface area, physical,
ther mal and chemical stability, and pore size, and adequate pore size. Advancing in this
sense, this work studies the usage of: Haloperidol Release from ZnO nanocrystal Coated
SWCNT, with 30nm of wide and 5 um of long, which by the effect of the interaction
between the host and drug molecules and by diffusion through the porosity, leads to
a substantial contribution to controlled drug release. The reduction in the dose and
frequency of administration, possible improvement in the selectivity of the
pharmacological activity, and a prolonged therapeutic effect.
CNT prepared by sol gel method (using the same technique describe by us, [3]), but at
different pH and long range of pristine mesoporous carbons material calcination, to
obtain SWCNTs. The posterior deposition of ZnO, was obtained, employing ZnNO3,
activated under N2 flow at 500ºC; offering adequate LUMO of Zn (the hybridized MO)
for Haloperidol interactions.
Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the
meso limbic system of the brain, thereby eliminat ing dopamine neurotransmission and
leading to antidelusionary and antihallucinagenic effects. Specifically, the dose of
Haloperidol (potent antipsychotic drug), indicates that its release follows the so called
"power law" or Weibull model, based on the results we obtained in our laboratory
(Figure 1).
Description
Keywords
ZnO SWCNT, Biomedical host, Antipsychotic drug, LUMO Zn--Halopeidol interaction, Haloperidol release, Weibull first order kinetic mode
Citation
Nanotech France 2023.
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as info:eu-repo/semantics/openAccess